Literature DB >> 16611962

Estrogens and breast cancer.

Charles L Blander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16611962     DOI： 10.1056/NEJMc060364

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.

Authors:  Chen Huang; Zhaogeng Cai; Mingzhu Huang; Chaoming Mao; Qifa Zhang; Yi Lin; Xiaomei Zhang; Bi Tang; Yuqing Chen; Xiaojing Wang; Zhongqing Qian; Lei Ye; Yongde Peng; Huanbai Xu
Journal:  J Clin Endocrinol Metab       Date:  2014-11-25       Impact factor: 5.958

2.  Estrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression.

Authors:  Chunhui Meng; Yan Zou; Weiwei Hong; Chunhua Bao; Xiaofeng Jia
Journal:  Mol Med       Date:  2020-04-09       Impact factor: 6.354

3.  EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.

Authors:  Liqiong Xue; Hongzhu Yan; Ying Chen; Qifa Zhang; Xin Xie; Xiaoying Ding; Xiaojing Wang; Zhongqing Qian; Feng Xiao; Zhiyi Song; Yijie Wu; Yongde Peng; Huanbai Xu
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.